iRadimed Corporation (IRMD) News
Filter IRMD News Items
IRMD News Results
|Loading, please wait...|
IRMD News Highlights
- For IRMD, its 30 day story count is now at 4.
- Over the past 15 days, the trend for IRMD's stories per day has been choppy and unclear. It has oscillated between 2 and 2.
Latest IRMD News From Around the Web
Below are the latest news stories about Iradimed Corp that investors may wish to consider to help them evaluate IRMD as an investment opportunity.
WINTER SPRINGS, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market opens on Friday, October 29 th . IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
Next-generation IV Infusion Pumps Market to Witness Huge Growth by Key Players: BD, Fresenius Kabi, Terumo, Medtronic, Baxter International, Hospira, iRadimed, Zyno Medical, Nipro, Summit Medical, Smiths Medical, Gamastech
Global Next-generation IV Infusion Pumps Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
IRadimed Corporation's (NASDAQ:IRMD) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
IRadimed's (NASDAQ:IRMD) stock is up by a considerable 19% over the past three months. However, we decided to pay...
Reports second quarter 2021 revenue of $9.8 million, GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.14Issues Q3 and full year 2021 financial guidance WINTER SPRINGS, Fla., July 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring sys
Products in Magnetic Resonance Imaging (MRI) Systems Markets Are Used To Diagnose and Monitor Almost Every Type of Disease
Launch of MRI compatible monitoring systems is expected to propel growth of the magnetic resonance imaging (MRI) systems market. In December 2019, Iradimed Corporation announced completion of the CE Mark renewal process for its MRI compatible patient vital signs monitoring
IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRadimed (IRMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
WINTER SPRINGS, Fla., July 07, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market opens on Friday, July 30th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-
iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.